John Forcier is an intellectual property attorney focusing on medical devices, water filtration, oil and gas, footwear and athletic apparel, and consumer products. John has represented big healthcare, big pharma, manufacturing companies, oil and gas, and filtration R&D companies for over 20 years in both law firm and in-house roles. John also spent 15 years as an engineer and project manager in the energy and consumer goods industries.
John focuses on the procurement, enforcement, and licensing of intellectual property rights, with emphasis on strategic development of U.S. and foreign patent portfolios, patent infringement and validity opinions, IPRs, reexaminations/reissues, oppositions, and IP diligence in a variety of high tech fields. One of the main aspects of his legal career is working with scientists and engineers in a variety of technologies to leverage their knowledge and experience to obtain numerous patents in the U.S. and abroad.
Legal Counsel, Animal Rescue League of Boston, 2010 – present
Any result the lawyer or law firm may have achieved on behalf of clients in other matters does not necessarily indicate similar results can be obtained for other clients.
- Successfully represented a large medical device company in numerous IPR proceedings in the U.S. Patent and Trademark Office (USPTO) to cancel a competitor’s patents covering electro-mechanical medical devices.
- Successfully represented a large telecommunication company in two IPR proceedings before the USPTO to cancel two patents that were asserted against the company.
- Ongoing representation of clients in the oil and gas industry in the prosecution of patents covering electro-mechanical devices.
- Preparation and global prosecution of patent applications in the fluid power, medical device, and consumer goods industries.
- Preparation and global prosecution, along with Freedom-to-Operate opinions, for a medical device company marketing cancer screening services.
- Development of patent portfolios for start-ups, venture-backed companies, public companies and research institutions.